{"id":"https://openalex.org/W1974569331","doi":"https://doi.org/10.1038/sj.bjp.0706041","title":"The dual PPAR\u03b1/\u03b3 agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats","display_name":"The dual PPAR\u03b1/\u03b3 agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats","alternate_titles":[],"publication_year":2005,"publication_date":"2005-01-17","ids":{"openalex":"https://openalex.org/W1974569331","doi":"https://doi.org/10.1038/sj.bjp.0706041","mag":"1974569331","pmid":"https://pubmed.ncbi.nlm.nih.gov/15655531","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1576007"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0706041","doi":"https://doi.org/10.1038/sj.bjp.0706041","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0706041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706041","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1974569331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706041","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111844368","display_name":"Lucy C. Pickavance","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Lucy C Pickavance","raw_affiliation_strings":["Department of Veterinary Preclinical Sciences, University of Liverpool, Brownlow Hill/Crown St., Liverpool L69 7ZJ, UK. lucyp@liverpool.ac.uk","Department of Veterinary Preclinical Sciences, University of Liverpool, Brownlow Hill/Crown St., Liverpool, L69 7ZJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterinary Preclinical Sciences, University of Liverpool, Brownlow Hill/Crown St., Liverpool L69 7ZJ, UK. lucyp@liverpool.ac.uk","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Department of Veterinary Preclinical Sciences, University of Liverpool, Brownlow Hill/Crown St., Liverpool, L69 7ZJ","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013301991","display_name":"Christian Lehn Brand","orcid":"https://orcid.org/0000-0002-7355-4448","observed_orcids":["https://orcid.org/0000-0002-7355-4448"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Christian L Brand","raw_affiliation_strings":["Research and Development, Novo Nordisk A/S, Bagsvaerd and Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Novo Nordisk A/S, Bagsvaerd and Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028655677","display_name":"Karsten Wassermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karsten Wassermann","raw_affiliation_strings":["Novo Nordisk Pharmaceuticals Inc., Princeton, NJ, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharmaceuticals Inc., Princeton, NJ, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047195042","display_name":"John P.H. Wilding","orcid":"https://orcid.org/0000-0003-2839-8404","observed_orcids":["https://orcid.org/0000-0003-2839-8404"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John P H Wilding","raw_affiliation_strings":["Department of Medicine, University of Liverpool, Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Liverpool, Liverpool","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111844368"],"corresponding_institution_ids":["https://openalex.org/I146655781"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.9716,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.91939221,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"144","issue":"3","first_page":"308","last_page":"316"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9269999861717224},{"id":"https://openalex.org/keywords/bezafibrate","display_name":"bezafibrate","score":0.9710000157356262},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7900000214576721},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9509999752044678},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hyperglycaemic-clamp","display_name":"hyperglycaemic clamp","score":0.8169999718666077},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.6179999709129333},{"id":"https://openalex.org/keywords/zucker-diabetic-fatty-rats","display_name":"Zucker diabetic fatty rats","score":0.8410000205039978},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.7170000076293945},{"id":"https://openalex.org/keywords/plasma-lipids","display_name":"plasma lipids","score":0.8190000057220459},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8413342237472534},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8365216851234436},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7962652444839478},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.754401683807373},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7412688732147217},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6001066565513611},{"id":"https://openalex.org/C2778808658","wikidata":"https://www.wikidata.org/wiki/Q2975183","display_name":"Glucose clamp technique","level":5,"score":0.5271926522254944},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5247309803962708},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5200031399726868},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4796907603740692},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.4440747797489166},{"id":"https://openalex.org/C2780352109","wikidata":"https://www.wikidata.org/wiki/Q728309","display_name":"Pancreatic hormone","level":4,"score":0.26041555404663086},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21131032705307007}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001629","descriptor_name":"Bezafibrate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001823","descriptor_name":"Body Composition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004734","descriptor_name":"Energy Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009929","descriptor_name":"Organ Size","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010179","descriptor_name":"Pancreas","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015309","descriptor_name":"Glucose Clamp Technique","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054411","descriptor_name":"Receptors, Leptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0706041","doi":"https://doi.org/10.1038/sj.bjp.0706041","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0706041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706041","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:15655531","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15655531","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1576007","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1576007/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0706041","doi":"https://doi.org/10.1038/sj.bjp.0706041","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0706041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706041","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320323","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1974569331.pdf","grobid_xml":"https://content.openalex.org/works/W1974569331.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W36311596","https://openalex.org/W599108204","https://openalex.org/W1643947316","https://openalex.org/W1960744144","https://openalex.org/W1968237817","https://openalex.org/W1969833341","https://openalex.org/W1971269545","https://openalex.org/W1977004017","https://openalex.org/W1977666051","https://openalex.org/W1980662936","https://openalex.org/W2002711503","https://openalex.org/W2017244979","https://openalex.org/W2019950192","https://openalex.org/W2023463659","https://openalex.org/W2029410945","https://openalex.org/W2034577350","https://openalex.org/W2042905537","https://openalex.org/W2047982128","https://openalex.org/W2054762675","https://openalex.org/W2054981406","https://openalex.org/W2060752803","https://openalex.org/W2064560407","https://openalex.org/W2067357198","https://openalex.org/W2081824649","https://openalex.org/W2092621119","https://openalex.org/W2096773810","https://openalex.org/W2100131441","https://openalex.org/W2105470307","https://openalex.org/W2121210060","https://openalex.org/W2121496639","https://openalex.org/W2125344994","https://openalex.org/W2128639389","https://openalex.org/W2129950813","https://openalex.org/W2136711907","https://openalex.org/W2137046761","https://openalex.org/W2146363516","https://openalex.org/W2153238954","https://openalex.org/W2160234571","https://openalex.org/W2169224393","https://openalex.org/W2171716790","https://openalex.org/W2590456671","https://openalex.org/W2607031541","https://openalex.org/W2904973415"],"related_works":["https://openalex.org/W2064560407","https://openalex.org/W2127588320","https://openalex.org/W2092621119","https://openalex.org/W2108672863","https://openalex.org/W2171024875","https://openalex.org/W2162264116","https://openalex.org/W2153238954","https://openalex.org/W2088254905","https://openalex.org/W2100400393"],"abstract_inverted_index":{"In":[0,36],"6-":[1],"and":[2,14,25,28,33,52,75,84,91,141,188,221],"10-week-old":[3],"obesity-prone":[4],"(fa/fa)":[5],"Zucker":[6],"diabetic":[7],"fatty":[8],"(ZDF)":[9],"rats,":[10,196],"effects":[11],"of":[12,204],"prevention":[13,83,88,140,171],"intervention":[15,85,142,150],"therapies,":[16,143],"respectively,":[17],"were":[18,55,111],"compared":[19],"between":[20],"PPARalpha/gamma":[21],"agonist,":[22],"ragaglitazar":[23],"(RAGA)":[24],"separate":[26,38],"PPARgamma":[27],"alpha":[29],"agonists,":[30],"pioglitazone":[31],"(PIO)":[32],"bezafibrate":[34],"(BF).":[35],"a":[37,65,126],"study,":[39],"lean":[40],"(+/+)":[41],"ZDF":[42,195],"rats":[43,79],"fed":[44],"highly":[45],"palatable":[46],"chow":[47],"to":[48,81,122,125,170],"induce":[49],"dietary":[50],"obesity":[51],"insulin":[53,155,182,220],"resistance":[54],"treated":[56],"similarly.":[57],"To":[58],"test":[59],"insulin-secretory":[60,178],"capacity,":[61],"all":[62,119],"animals":[63,168],"underwent":[64],"hyperglycaemic":[66,227],"clamp.":[67],"Insulin":[68],"sensitivity":[69],"was":[70,95,163,175,184],"improved":[71,132,154],"equally":[72,190],"by":[73,116],"RAGA":[74,117,131,187],"PIO":[76,145,189],"in":[77,106,118,149,166,194,201,230],"fa/fa":[78],"subjected":[80,169],"both":[82],"treatments":[86],"(e.g.,":[87],"HOMA-IR:":[89],"-71":[90],"-72%,":[92],"respectively),":[93],"as":[94],"hyperglycaemia":[96],"(both":[97],"-68%).":[98],"BF":[99],"had":[100],"no":[101],"effect":[102],"on":[103],"either":[104],"parameter":[105],"any":[107],"study.":[108],"Plasma":[109],"lipids":[110],"markedly":[112],"reduced":[113],"(by":[114],"48-77%)":[115],"studies,":[120],"equivalent":[121],"PIO,":[123],"but":[124,173],"greater":[127],"extent":[128],"than":[129,137,224],"BF.":[130],"beta-cell":[133,209],"function":[134],"(HOMA-beta)":[135],"more":[136],"three-fold":[138],"with":[139,153],"whereas":[144],"showed":[146],"improvement":[147],"only":[148],"therapy.":[151],"Consistent":[152],"sensitivity,":[156],"glucose":[157,222],"infusion":[158],"rate":[159],"during":[160],"the":[161,202,226],"clamp":[162,228],"60%":[164],"higher":[165],"RAGA-treated":[167],"therapy,":[172],"there":[174],"little":[176],"additional":[177],"response,":[179],"suggesting":[180],"that":[181],"secretion":[183],"already":[185],"maximal.Thus,":[186],"improve":[191,208],"metabolic":[192],"profile":[193],"particularly":[197],"when":[198],"administered":[199],"early":[200],"course":[203],"diabetes.":[205],"They":[206],"also":[207],"function,":[210],"although":[211],"this":[212,231],"is":[213],"better":[214],"demonstrated":[215],"through":[216,225],"indices":[217],"incorporating":[218],"fasting":[219],"concentrations":[223],"technique":[229],"model.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1974569331","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
